What is an Orphan Drug Designation and why it Matters

The FDA Orphan Drug Designation is a regulatory pathway that encourages the development of treatments for rare diseases.
It offers advantages such as:

• regulatory support
   

• tax incentives
   

• fee waivers
   

• seven years of market exclusivity
   

For patients, an ODD can mean faster access, formal recognition of a treatment, and a higher likelihood of reimbursement.

For more information visit the FDA website on the link right here: